Advertisement

Small Molecule Selectivity and Specificity Profiling Using Functional Protein Microarrays

  • Peter R. Kraus
  • Lihao Meng
  • Lisa Freeman-Cook
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 632)

Abstract

Small molecules interact with proteins to perturb their functions, a property that has been exploited both for research applications and to produce therapeutic agents for disease treatment. Commonly utilized approaches for identifying the target proteins for a small molecule have limitations in terms of throughput and resource consumption and lack a mechanism to broadly assess the selectivity profile of the small molecule. Here we describe how protein microarray technology can be applied to the study of small molecule-protein interactions using tritiated small molecules. Protein arrays comprising thousands of full-length functional proteins facilitate target identification for those small molecules discovered in cell-based phenotypic assays and both target validation and off-target binding assessment for compounds discovered in target-based screens. The assays are highly reproducible, sensitive, and scalable, and provide an enabling technology for small molecule selectivity profiling in the context of drug development.

Key words

Protein-small molecule interaction Small molecule Protein microarray Off target effect Selectivity profiling Specificity profiling 

References

  1. 1.
    Predki PF (2004) Functional protein microarrays: ripe for discovery. Curr Opin Chem Biol 8:8-13PubMedCrossRefGoogle Scholar
  2. 2.
    Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ (2007) A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 17:1-7CrossRefGoogle Scholar
  3. 3.
    Gupta R, Kus B, Fladd C, Wasmuth J, Tonikian R, Sidhu S, Krogan NJ, Parkinson J, Rotin D (2007) Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast. Mol Systems Biol 3(116):1-12Google Scholar
  4. 4.
    Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 104:17494-17499PubMedCrossRefGoogle Scholar
  5. 5.
    Satoh J, Obayashi S, Misawa T, Sumiyoshi K, Oosumi K, Abunoki H (2008) Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 35:16-35PubMedCrossRefGoogle Scholar
  6. 6.
    Schnack C, Hengerer B, Gillardon F (2008) Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 8:1980-6PubMedCrossRefGoogle Scholar
  7. 7.
    MacBeath G, Schreiber SL (2000) Printing proteins as microarrays for high-throughput function determination. Science 289:1760-3PubMedGoogle Scholar
  8. 8.
    Ge H (2000) UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA, and protein-ligand interactions. Nucleic Acids Res 28:e3PubMedCrossRefGoogle Scholar
  9. 9.
    Fang Y, Frutos AG, Lahiri J (2002) Membrane protein microarrays. J Am Chem Soc 124:2394-5PubMedCrossRefGoogle Scholar
  10. 10.
    Schweitzer B, Predki P, Snyder M (2003) Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 3:2190-9PubMedCrossRefGoogle Scholar
  11. 11.
    Huang J, Zhu H, Haggarty SJ, Spring DR, Hwang H, Jin F, Snyder M, Schreiber SL (2004) Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Natl Acad Sci USA 101:16594-9PubMedCrossRefGoogle Scholar
  12. 12.
    Singh J, Salcius M, Liu S-W, Staker BL, Mishra R, Thurmond J, Michaud G, Mattoon DR, Printen J, Christensen J, Bjornsson JM, Pollok BA, Kiledjian M, Stewart L, Jarecki J, Gurney ME (2008) DcpS as a therapeutic target for Spinal Muscular Atrophy. ACS Chem Biol 3:711-22PubMedCrossRefGoogle Scholar
  13. 13.
    Zhang J-H, Chung TDY, Oldenburg KR (2000) Confirmation of primary active substances from high-throughput screening of chemical and biological populations: A statistical approach and practical considerations. J Com Chem 2:258-265CrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Peter R. Kraus
    • 1
  • Lihao Meng
    • 1
  • Lisa Freeman-Cook
    • 1
  1. 1.Life TechnologiesCarlsbadUSA

Personalised recommendations